ATH

11.1%

0.5¢ alterity therapeutics limited

Iron, central in the PD pathology,, page-3

First 3 Last

Share
Profile

Follow
gumboot

383 Posts.

19

16/10/21

17:38

Post #: 56851074
Share
Originally posted by pivalde: ↑

Iron as the concertmaster in the pathogenic orchestra playing in sporadic Parkinson’s disease | SpringerLink

This paper tells "everything" how iron plays a central role in PD pathology. So it is a good paper to read if you want to understand why iron chelation by ATH434 could work in helping PD patients. It is not written by the top scientist of neurodegeneration but it tells IMO the most central issues.

The halfway conclusions were:

IRON increases with age.
IRON transfer through BBB is increased.
IRON export from brain is increased.
IRON is increased in SN blood vessels.
IRON storage by ferritin and neuromelanin is dysregulated.
Free/labile IRON increases and induces Fenton reaction leading to toxic hydroxyl radicals.
Ferroptosis causes proteasomal defect, mitochondrial disturbances and cellular cytotoxic processes, lysosomal defects, apoptosis and autophagy dysregulation, all together causing cell degeneration. Ferroptosis is characterized by an accumulation of lipid hydroperoxides (Dixon Scott et al.2012). The sensitivity to ferroptosis is linked to numerous biological processes and in particular to iron, glutathione, phospholipid, NADPH, coenzyme Q₁₀and polyunsaturated fatty acid metabolism (Yan and Zhang2020; Stockwell et al.2017). A deficient regulation of ferroptosis has been found in MPTP-treated mice (Tapias2019), a model of PD pathology (Fig.3).

But there is more when you continue after these conclusions including a very long list of references.
It is easy to agree with the final conclusions in the abstract:
"iron" is a major player in the pathology of PD. Selective chelation of excess iron at the site of the substantia nigra, where a dysfunction of the BBB is suggested, with peripherally acting iron chelators is suggested to contribute to the portfolio and therapeutic armamentarium of anti-Parkinson medications.

Now ATH needs to present that ATH434 works also in human PD. I would think that the primate study will come before that and most likely it is already going on somewhere.

Expand

Thanks Pivalde.
After reading the full paper, which is an omnibus of papers, I hope someone with more smarts than me can confirm it's relevance,
inasmuch as it convincingly links Fe with movement disorders and even throws in Fe in Covid 19
ATH Price at posting: 3.2¢ Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

EMD

Emyria's Empax Centre chosen for mental health clinical trial

SBW

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

RDN

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

FHE

Frontier Energy achieves key milestone for Waroona energy project

AML

Cultural heritage agreement puts Walford Creek exploration back on the map

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

BRX

Belararox delineates another porphyry in Argentina at Tambo South

Plagues precede widespread power shifts. We’re living in one – and minerals are at the fore

ASX Market Update: Shares fall flat as GYG soars on debut | 20 June, 2024

STX

Strike Energy secures $153 million for Perth Basin gas projects

There are more pages in this discussion • 1 more message in this thread...

First 3 Last

Add ATH (ASX) to my watchlist

(20min delay)
Last 0.5¢		Change 0.001(11.1%)		Mkt cap ! $26.22M

Open	High	Low	Value	Volume
0.4¢	0.5¢	0.4¢	$14.25K	2.930M

Buyers (Bids)

No.	Vol.	Price($)
66	81346070	0.4¢

Sellers (Offers)

Price($)	Vol.	No.
0.5¢	19609447	23

View Market Depth

No.	Vol.	Price($)
63	79721070	0.004
53	53345564	0.003
15	38495514	0.002
15	94665101	0.001
0	0	0.000

Price($)	Vol.	No.
0.005	19609447	23
0.006	34372301	14
0.007	18091596	18
0.008	14950875	15
0.009	6000000	5

Last trade - 16.10pm 21/06/2024 (20 minute delay)

ATH (ASX) Chart

Iron, central in the PD pathology,, page-3

Emyria's Empax Centre chosen for mental health clinical trial

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

Frontier Energy achieves key milestone for Waroona energy project

Cultural heritage agreement puts Walford Creek exploration back on the map

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

Belararox delineates another porphyry in Argentina at Tambo South

Plagues precede widespread power shifts. We’re living in one – and minerals are at the fore

ASX Market Update: Shares fall flat as GYG soars on debut | 20 June, 2024

Strike Energy secures $153 million for Perth Basin gas projects

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Iron, central in the PD pathology,, page-3

Top Stories

Emyria's Empax Centre chosen for mental health clinical trial

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

Frontier Energy achieves key milestone for Waroona energy project

Cultural heritage agreement puts Walford Creek exploration back on the map

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

Belararox delineates another porphyry in Argentina at Tambo South

Plagues precede widespread power shifts. We’re living in one – and minerals are at the fore

ASX Market Update: Shares fall flat as GYG soars on debut | 20 June, 2024

Strike Energy secures $153 million for Perth Basin gas projects

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News